Contact
searchSearch
HMP Global

Current Issue

Interview
New MAUDE Analysis Highlights Real-World Mechanical Thrombectomy Complications
05/18/2026
Chloe Issa, MD; Sarah Montaquila, DO
Drs Issa and Montaquila discuss their analysis of FDA MAUDE data examining adverse events in venous and pulmonary mechanical thrombectomy systems.
Drs Issa and Montaquila discuss their analysis of FDA MAUDE data examining adverse events in venous and pulmonary mechanical thrombectomy systems.
Drs Issa and Montaquila discuss...
05/18/2026
Vascular Disease Management
Interview
New Insights on Thrombectomy in Atrial Fibrillation-Related Stroke
05/06/2026
Waseem Wahood, MD
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends...
05/06/2026
Vascular Disease Management
Literature Review
Microplastics as Triggers of Immunothrombosis: Linking Environmental Exposure to Cardiovascular Events
05/01/2026
Abiya Ahad, MBBS; Darshan Hullon, DO
The authors delineate how ingested, inhaled, and iatrogenically introduced particles breach biological barriers, enter systemic circulation, and engage endothelial cells, monocytes, macrophages, neutrophils, and platelets.
The authors delineate how ingested, inhaled, and iatrogenically introduced particles breach biological barriers, enter systemic circulation, and engage endothelial cells, monocytes, macrophages, neutrophils, and platelets.
The authors delineate how...
05/01/2026
Vascular Disease Management
Author

Stay in the Know

Vascular Disease Management Newsletter

News

Thrombectomy
Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio
05/20/2026
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS...
05/20/2026
Vascular Disease Management
Intravascular Lithotripsy
Cagent Vascular Reports First Human Use of Serranator® SONIC IVL System and Closes Oversubscribed $41M Series D Financing
05/19/2026
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical...
05/19/2026
Vascular Disease Management
Arterial and Venous Embolization
Medtronic Announces Successful Early Commercial Use of Concerto Versa™ Detachable Coil
05/18/2026
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully...
05/18/2026
Vascular Disease Management
Clinical Trials
Surrogate Endpoints Remain a Challenge in Interventional Oncology Trials
05/12/2026
Laura Simson, MA
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined the strengths and limitations of surrogate endpoints in interventional oncology clinical trials.
A 2026 review article examined...
05/12/2026
Vascular Disease Management
IVUS+OCT
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
05/08/2026
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging  - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO-- Conavi Medical Corp.,...
- First co-registered and...
05/08/2026
Cath Lab Digest
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Pulmonary embolism
Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study
05/01/2026
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in...
05/01/2026
Vascular Disease Management
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Sirolimus-coated Balloons
Concept Medical Announces Preliminary 3-Year Sirona Data at Charing Cross Symposium 2026
04/28/2026
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data...
04/28/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use